Michael Wiley - Guardant Health Chief Legal Officer

GH Stock  USD 17.96  0.27  1.53%   

Executive

Mr. Michael J Wiley, J.D., CPA, is a Chief Legal Officer of the Company. Michael joined Guardant Health in 2012 as President and became its Chief Financial Officer in 2013 and its Chief Legal Officer in 2016. Prior to joining Guardant, Michael worked as CFO at Voyage Medical, a medical device company. Before Voyage, Michael was VP of Finance at Microchip Biotechnologies, Inc., where he led the team that raised both Series A and Series B financings for the company. Earlier in his career, Michael was a corporate attorney at Venture Law Group and acted as inhouse associate counsel for Novell where he focused on intellectual property and employment issues. Before receiving a JD J. Reuben Clark Law School at Brigham Young University, Michael worked for KPMG as a tax accountant. since 2016.
Age 42
Tenure 8 years
Professional MarksCPA
Address 3100 Hanover Street, Palo Alto, CA, United States, 94304
Phone855 698 8887
Webhttps://guardanthealth.com
Wiley received a J.D. degree from the J. Reuben Clark Law School at Brigham Young University and a B.S. degree in accounting from Brigham Young University.

Michael Wiley Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael Wiley against Guardant Health stock is an integral part of due diligence when investing in Guardant Health. Michael Wiley insider activity provides valuable insight into whether Guardant Health is net buyers or sellers over its current business cycle. Note, Guardant Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Guardant Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Guardant Health Management Efficiency

The company has Return on Asset (ROA) of (0.1764) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1764. This is way below average. Likewise, it shows a return on total equity (ROE) of (4.3813) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Capital Employed is estimated to decrease to -0.37. The current Return On Assets is estimated to decrease to -0.28. As of now, Guardant Health's Fixed Asset Turnover is increasing as compared to previous years.
The company reports 1.35 B of total liabilities with total debt to equity ratio (D/E) of 4.32, which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Guardant Health has a current ratio of 6.06, indicating that it is in good position to pay out its debt commitments in time. Debt can assist Guardant Health until it has trouble settling it off, either with new capital or with free cash flow. So, Guardant Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Guardant Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Guardant to invest in growth at high rates of return. When we think about Guardant Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

MD FACSSpectral AI
N/A
Dirksen LehmanEdwards Lifesciences Corp
N/A
Christine McCauleyEdwards Lifesciences Corp
59
Ilan OrenMedigus Ltd ADR
N/A
Ram SharmaDefinitive Healthcare Corp
N/A
Pr ChadwickSpectral AI
N/A
Vincent CaponeSpectral AI
N/A
Jeffrey ThatcherSpectral AI
40
Liron CarmelMedigus Ltd ADR
39
David BronsonSpectral AI
N/A
Tatyana YossefMedigus Ltd ADR
29
Christine MarksSpectral AI
N/A
MD FACCEdwards Lifesciences Corp
N/A
Juan DiazCartelleMicrobot Medical
N/A
Matt RudermanDefinitive Healthcare Corp
N/A
Peter CPASpectral AI
60
Mark WilterdingEdwards Lifesciences Corp
N/A
Niko PagoulatosSpectral AI
50
Carrie LazorchakDefinitive Healthcare Corp
N/A
Craig HazenfieldDefinitive Healthcare Corp
N/A
Arnold PinkstonEdwards Lifesciences Corp
65
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1373 people. Guardant Health (GH) is traded on NASDAQ Exchange in USA. It is located in 3100 Hanover Street, Palo Alto, CA, United States, 94304 and employs 1,768 people. Guardant Health is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Guardant Health Leadership Team

Elected by the shareholders, the Guardant Health's board of directors comprises two types of representatives: Guardant Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guardant. The board's role is to monitor Guardant Health's management team and ensure that shareholders' interests are well served. Guardant Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guardant Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
AmirAli Talasaz, President COO, Director
Richard Lanman, Chief Medical Officer
Marcel Roche, Vice President - Finance
Ian Clark, Lead Independent Director
Leena DasYoung, General Manager,Chief LUNAR Officer
John Saia, Chief Secretary
DEREK BERTOCCI, CFO
Terilyn Monroe, Chief Officer
Craig MD, Chief Officer
Andy Ament, VP Operations
Kumud Kalia, Chief Officer
Michael Bell, Chief Officer
Michael Wiley, Chief Legal Officer
Aaref Hilaly, Independent Director
Darl Moreland, Senior Quality
Jennifer Higgins, Vice Affairs
Dipchand Nishar, Independent Director
Christopher Freeman, Chief Officer
Helmy Eltoukhy, CoCEO CoFounder
Mark Jacobstein, Chief User Engagement Officer
Bahija Jallal, Director
Stanley Meresman, Independent Director
Lynn Lewis, IR Contact Officer
Darya Chudova, VP Technology
Samir Kaul, Independent Director

Guardant Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Guardant Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Guardant Health Investors Sentiment

The influence of Guardant Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Guardant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Guardant Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Guardant Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Guardant Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Guardant Health's short interest history, or implied volatility extrapolated from Guardant Health options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
5.036
Quarterly Revenue Growth
0.222
Return On Assets
(0.18)
Return On Equity
(4.38)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.